Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Watchlist Manager
Zylox-Tonbridge Medical Technology Co Ltd Logo
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Watchlist
Price: 15.94 HKD -1.6% Market Closed
Market Cap: 5.2B HKD

Zylox-Tonbridge Medical Technology Co Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zylox-Tonbridge Medical Technology Co Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Net Change in Cash
-ÂĄ118.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Net Change in Cash
ÂĄ1B
CAGR 3-Years
180%
CAGR 5-Years
146%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Net Change in Cash
ÂĄ81.5m
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
7%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Net Change in Cash
-ÂĄ953.4m
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Net Change in Cash
-ÂĄ1.4B
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
-31%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Net Change in Cash
-ÂĄ2.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Zylox-Tonbridge Medical Technology Co Ltd
Glance View

Market Cap
5.2B HKD
Industry
Health Care

Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.

Intrinsic Value
14.63 HKD
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Zylox-Tonbridge Medical Technology Co Ltd's Net Change in Cash?
Net Change in Cash
-118.7m CNY

Based on the financial report for Dec 31, 2024, Zylox-Tonbridge Medical Technology Co Ltd's Net Change in Cash amounts to -118.7m CNY.

What is Zylox-Tonbridge Medical Technology Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
0%

Over the last year, the Net Change in Cash growth was 0%.

Back to Top